InVivo Therapeutics Email Format

Medical Equipment ManufacturingMassachusetts, United States2-10 Employees

InVivo Therapeutics, based in Cambridge, Massachusetts, conducts research and clinical development in biomaterials aimed at treating spinal cord injuries. Founded in 2005 with proprietary technology co-invented by MIT’s Robert Langer and Joseph Vacanti, the company’s core focus is the Neuro-Spinal Scaffold, a biodegradable implant placed at the injury site to support healing, reduce cavity formation, spare white matter, and foster neural regeneration across the damaged area. The scaffold has a Humanitarian Use Device designation and is being evaluated in the INSPIRE pivotal study for complete traumatic acute spinal cord injury (AIS A). 

The company serves clinicians and surgeons handling acute spinal cord injuries, offering a device intended to improve tissue preservation and neural recovery after injury. In addition to its lead program, it has pursued collaborations and disseminated INSPIRE-related findings, including a past joint research agreement with Q Therapeutics, reflecting ongoing clinical development in this field.

Get verified InVivo Therapeutics emails free

Company overview Employee directory